C12N 2710/10234
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2710/10234 (Use of virus or viral component as vaccine) appears on 15 US grants and 20 published applications in this corpus.
Search patents in C12N- Granted patents
- 15
- Published applications
- 20
- Assignees
- 18
- Inventors
- 61
- Latest grant
- 14 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 0 | 1 |
| 2015 | 1 | 1 |
| 2016 | 2 | 3 |
| 2017 | 0 | 2 |
| 2018 | 1 | 1 |
| 2019 | 2 | 0 |
| 2020 | 1 | 1 |
| 2021 | 0 | 0 |
| 2022 | 3 | 5 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- tFIBER protein fragment of avian egg drop syndrome virus and vaccine composition prepared thereof, preparation method and use14 Oct 2025US 12,440,551 B2Pulike Biological Engineering, Inc.
- Avian influenza and fowl adenovirus type 4 bi-combined genetic engineering subunit vaccine and method for preparing the same19 Apr 2022US 11,305,006 B2Zhaoqing Dahuanong Biology Medicine Co., Ltd
- Heat-resistant recombinant Newcastle Disease Virus vaccine strain capable of expressing truncated Fiber 2 protein of Fowl Adenovirus serotype 4, preparation method and application thereof29 Mar 2022US 11,285,206 B2Institute of Animal Husbandry and Veterinary Sciences, Hubei Academy of Agricultural Sciences
- Obtainment of a rough-type Salmonella enteritidis and its genetic modifications for use as an avian vaccine8 Feb 2022US 11,242,521 B2Farmacologicos Veterinarios S.A.C.—Farvet
- Vaccine in the form of a recombinant sero type 9 avian adenovirus vector1 Sep 2020US 10,758,608 B2Grupo Industrial Pecuario, S.A. De C.V.
- Fowl adenovirus subunit vaccine and production method thereof20 Feb 2025US 2025/0057943 A1Veterinarmedizinische Universitat Wien
- Veterinary viral vector29 Aug 2024US 2024/0285748 A1
- Large-scale combined car transduction and crispr gene editing of t cells22 Dec 2022US 2022/0401479 A1Board of Regents, The University of Texas System
- Tfiber protein fragment of avian egg drop syndrome virus and vaccine composition prepared thereof, preparation method and use25 Aug 2022US 2022/0265811 A1Pulike Biological Engineering, Inc.
- Stabilized non-enveloped virus compositions31 Mar 2022US 2022/0096375 A1Ziccum AB
Most cited
By later US patents
- Propagation of hemorrhagic enteritis virus in a turkey cell line and vaccine produced17US 4,388,298 AThe United States of America as represented by the Secretary of Agriculture · 1983
- Vaccines for immunizing egg-laying birds against Egg Drop disease, preparation of said vaccines, and method of use of said vaccines7US 4,302,444 AAkzo N. V. · 1981
- Recombinant avian adenovirus vector3US 6,296,852 B1Commonwealth Scientific and Industrial Research Organisation · 2001
- LPS vaccine1US 9,345,756 B2The Chemo-Sero-Therapeutic Research Institute · 2016